Clinical Trial Update: Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With Sublingual Cyclobenzaprine HCl (TNX-102 SL) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sublingual cyclobenzaprine HCl (TNX-102 SL) to prevent or reduce acute stress reactions and PTSD in a civilian population; recruitment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder
• Stress Disorder

Drugs mentioned

• TNX-102 SL (cyclobenzaprine hydrochloride)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Acute Stress Reaction, Acute Stress Disorder | Phase 2 | Status: RECRUITING